BAR Antibodies

Santa Cruz Biotechnology provides a broad selection of BAR Antibodies for advanced research in cellular signaling and regulation. BAR antibodies are effective tools for various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The BAR (Bcl-2/Adenovirus E1B 19 kDa Interacting Protein) family of proteins plays a key role in regulating apoptosis and cellular survival, making them essential for understanding cancer biology and other diseases. By modulating the balance between pro-apoptotic and anti-apoptotic signals, BAR proteins influence cell fate decisions and are implicated in various pathological conditions. The study of BAR proteins is vital for developing targeted therapies and advancing our understanding of cellular mechanisms. Research in this area continues to reveal new insights about cell death regulation and its impact on disease progression. Ongoing studies highlight the significance of BAR proteins in maintaining cellular homeostasis and their potential as therapeutic targets. Researchers worldwide are uncovering new functions and regulatory mechanisms of BAR proteins in different cellular processes. Santa Cruz Biotechnology BAR monoclonal antibodies support cutting-edge research in cell biology and disease mechanisms.